暂无分享,去创建一个
Ye Yuan | Kai Zheng | Alex Carderas | Itamar Livnat | Ryan Yanagihara | Rosita Saul | Gabrielle Montes De Oca | Andrew W. Browne | A. Browne | R. Yanagihara | G. F. D. Oca | I. Livnat | Rosita Saul | Ye Yuan | K. Zheng | Alex Carderas
[1] Guannan Gao,et al. Probabilistic Hough Transform , 2011 .
[2] Paul Mitchell,et al. Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review , 2013, British Journal of Ophthalmology.
[3] Glenn J Jaffe,et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. , 2014, Ophthalmology.
[4] B. Yaspan,et al. Mechanisms of age‐related macular degeneration and therapeutic opportunities , 2014, The Journal of pathology.
[5] Xiaoling Xia,et al. Inception-v3 for flower classification , 2017, 2017 2nd International Conference on Image, Vision and Computing (ICIVC).
[6] Jost B Jonas,et al. Global prevalence of age-related macular degeneration. , 2014, The Lancet. Global health.
[7] Yara T. E. Lechanteur,et al. Prevalence of Age-Related Macular Degeneration in Europe , 2017, Ophthalmology.
[8] Chew Lim Tan,et al. A system for understanding imaged infographics and its applications , 2007, DocEng '07.
[9] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[10] Diego Klabjan,et al. Data Extraction from Charts via Single Deep Neural Network , 2019, ArXiv.
[11] Laure Huot,et al. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. , 2013, Ophthalmology.
[12] R. Smith,et al. An Overview of the Tesseract OCR Engine , 2007, Ninth International Conference on Document Analysis and Recognition (ICDAR 2007).
[13] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[14] Derek Bradley,et al. Adaptive Thresholding using the Integral Image , 2007, J. Graph. Tools.
[15] Peter K Kaiser,et al. Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis). , 2009, Transactions of the American Ophthalmological Society.
[16] Kaiming He,et al. Faster R-CNN: Towards Real-Time Object Detection with Region Proposal Networks , 2015, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[17] Eric P. Xing,et al. Structured Literature Image Finder: Extracting Information from Text and Images in Biomedical Literature , 2009, BioLINK@ISMB/ECCB.
[18] Won Ki Lee,et al. Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial , 2017, JAMA ophthalmology.
[19] R. Klein,et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. , 2014, The Lancet. Global health.
[20] Luc Van Gool,et al. A+: Adjusted Anchored Neighborhood Regression for Fast Super-Resolution , 2014, ACCV.
[21] Hagit Shatkay,et al. Segmenting Compound Biomedical Figures into Their Constituent Panels , 2017, CLEF.
[22] S Sivaprasad,et al. Is it necessary to use three mandatory loading doses when commencing therapy for neovascular age-related macular degeneration using bevacizumab? (BeMOc Trial) , 2013, Eye.
[23] C. Regillo,et al. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. , 2008, American journal of ophthalmology.
[24] Michael W Kattan,et al. Meta-analysis: Its strengths and limitations. , 2008, Cleveland Clinic journal of medicine.
[25] Manju Patel,et al. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. , 2006, Ophthalmology.
[26] Darius M Moshfeghi,et al. Stereotactic radiotherapy for neovascular age-related macular degeneration: year 2 results of the INTREPID study. , 2015, Ophthalmology.
[27] K. Eng,et al. Ranibizumab in neovascular age-related macular degeneration , 2006, Clinical interventions in aging.
[28] Michael Elad,et al. On Single Image Scale-Up Using Sparse-Representations , 2010, Curves and Surfaces.
[29] D. Giavarina. Understanding Bland Altman analysis , 2015, Biochemia medica.
[30] Jost B. Jonas,et al. Updates on the Epidemiology of Age‐Related Macular Degeneration , 2017, Asia-Pacific journal of ophthalmology.
[31] Jing Peng,et al. Bar charts detection and analysis in biomedical literature of PubMed Central , 2017, AMIA.
[32] Keiichi Abe,et al. Topological structural analysis of digitized binary images by border following , 1985, Comput. Vis. Graph. Image Process..
[33] Michael Larsen,et al. Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study. , 2018, Ophthalmology.
[34] Christophe Garcia,et al. ICDAR2015 competition on Text Image Super-Resolution , 2015, 2015 13th International Conference on Document Analysis and Recognition (ICDAR).
[35] Terje R Pedersen,et al. Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol. , 2015, Ophthalmology.
[36] Eric P. Xing,et al. Structured literature image finder: Parsing text and figures in biomedical literature , 2010, J. Web Semant..